Mark Pollack to Bacterial Toxins
This is a "connection" page, showing publications Mark Pollack has written about Bacterial Toxins.
Connection Strength
0.377
-
Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections. Am J Med. 1983 Jun; 74(6):980-7.
Score: 0.058
-
Pseudomonas aeruginosa exotoxin A inhibits proliferation of human bone marrow progenitor cells in vitro. Infect Immun. 1982 Oct; 38(1):206-11.
Score: 0.055
-
Toxoid from exotoxin A of Pseudomonas aeruginosa: preparation and characterization. J Infect Dis. 1982 May; 145(5):688-98.
Score: 0.053
-
Toxicity of Pseudomonas aeruginosa exotoxin A for human macrophages. Infect Immun. 1978 Mar; 19(3):1092-6.
Score: 0.040
-
Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2. Infect Immun. 1978 Jan; 19(1):29-33.
Score: 0.040
-
Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography. Infect Immun. 1978 Jan; 19(1):66-70.
Score: 0.040
-
Exotoxin production by clinical isolates of pseudomonas aeruginosa. Infect Immun. 1977 Mar; 15(3):776-80.
Score: 0.037
-
Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection. Infect Immun. 1976 Oct; 14(4):942-7.
Score: 0.036
-
Functionally distinct monoclonal antibodies reactive with enzymatically active and binding domains of Pseudomonas aeruginosa toxin A. Infect Immun. 1986 Jun; 52(3):756-62.
Score: 0.018